<?xml version="1.0" encoding="UTF-8"?>
<p id="p0160">Furthermore, thymoquinone decreases thyroid inflammation via the up-regulation of heme-oxygenase-1 expression and the suppression of cyclooxygenase-2 (COX-2) expression (
 <xref rid="b0195" ref-type="bibr">Khader and Eckl, 2014</xref>). 
 <italic>N. sativa</italic> L. powder administered at a dose of 1.7 mcg/kg body weight/day during eight weeks raised also T3 levels and reduced the synthesis of anti-TPO antibodies as well as the transforming growth factor (TGF)-β and interleukin (IL)–23 concentrations among forty patients with Hashimoto's thyroiditis aged between 20 and 50 years (
 <xref rid="b0345" ref-type="bibr">Tajmiri et al., 2016</xref>). 
 <xref rid="b0370" ref-type="bibr">Wang et al. (1998)</xref> have reported that vascular endothelial growth factor (VEGF) and its receptors (Flt-1) contribute to the developmental regulation of thyroid epithelial cells in adult Wistar rats after administration of goitrogen for two weeks. Studies have revealed that thymoquinone decreases VEGF levels (
 <xref rid="b0305" ref-type="bibr">Sethi et al., 2008</xref>) which are known to increase in response to the increase of TSH concentrations in patients suffering from chronic thyroiditis or thyroid cancer (
 <xref rid="b0140" ref-type="bibr">Farhangi et al., 2016</xref>).
</p>
